Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)

Q: What does CUSIP 761330109 represent in this 13F holders report?

CUSIP 761330109 is the security identifier for RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share in Q1 2020?

126 institutional investors reported RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share for Q1 2020. Use the holders table for investor-level position and value details.

CUSIP: 761330109

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 104,661,494
Total 13F shares: 49,442,358
Share change: -1,556,788
Total reported value: $731,960,359
Put/Call ratio: 72%
Price per share: $14.80
Number of holders: 126
Value change: -$26,411,053
Number of buys: 64
Number of sells: 56

Quarterly Holders Quick Answers

What is CUSIP 761330109?
CUSIP 761330109 identifies RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2020
Previous quarter: Q4 2019

Recent filing periods for CUSIP 761330109:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	5.5%	5,788,045	$93,940,000	—	31 Dec 2019	13F
ArrowMark Colorado Holdings LLC	13F	Company	4.6%	4,840,636	$78,564,000	—	31 Dec 2019	13F
JPMORGAN CHASE & CO	13F	Company	3.8%	4,024,157	$65,311,000	—	31 Dec 2019	13F
BlackRock Finance, Inc.	13F	Company	3.5%	3,688,657	$59,868,000	—	31 Dec 2019	13F
FRANKLIN RESOURCES INC	13F	Company	3.4%	3,582,972	$58,152,000	—	31 Dec 2019	13F
Essex Woodlands Management, Inc.	13F	Company	3.2%	3,342,047	$54,241,000	—	31 Dec 2019	13F
VANGUARD GROUP INC	13F	Company	2.4%	2,530,046	$41,063,000	—	31 Dec 2019	13F
Capital World Investors	13F	Company	2%	2,130,000	$34,570,000	—	31 Dec 2019	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	1.9%	1,950,975	$31,664,000	—	31 Dec 2019	13F
NovaQuest Capital Management, L.L.C.	13F	Company	1.5%	1,558,426	$25,293,000	—	31 Dec 2019	13F
Capital International Investors	13F	Company	1.1%	1,161,900	$18,858,000	—	31 Dec 2019	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	1%	1,066,128	$17,303,000	—	31 Dec 2019	13F
STATE STREET CORP	13F	Company	1%	1,055,390	$17,129,000	—	31 Dec 2019	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.86%	900,000	$14,607,000	—	31 Dec 2019	13F
BAMCO INC /NY/	13F	Company	0.79%	827,732	$13,434,000	—	31 Dec 2019	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.78%	820,377	$13,315,000	—	31 Dec 2019	13F
Polar Capital LLP	13F	Company	0.71%	745,135	$12,094,000	—	31 Dec 2019	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.65%	677,473	$10,995,000	—	31 Dec 2019	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.63%	656,013	$10,647,000	—	31 Dec 2019	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.57%	593,664	$9,635,000	—	31 Dec 2019	13F
NORTHERN TRUST CORP	13F	Company	0.56%	587,424	$9,534,000	—	31 Dec 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.56%	587,152	$9,529,000	—	31 Dec 2019	13F
ROTHSCHILD & CO ASSET MANAGEMENT US INC.	13F	Company	0.53%	559,764	$9,085,000	—	31 Dec 2019	13F
Fosun International Ltd	13F	Company	0.45%	472,532	$7,669,000	—	31 Dec 2019	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.4%	416,566	$6,761,000	—	31 Dec 2019	13F
Alyeska Investment Group, L.P.	13F	Company	0.38%	398,362	$6,465,000	—	31 Dec 2019	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.32%	336,729	$5,465,000	—	31 Dec 2019	13F
Bank of New York Mellon Corp	13F	Company	0.31%	327,864	$5,320,000	—	31 Dec 2019	13F
Nuveen Asset Management, LLC	13F	Company	0.31%	326,716	$5,303,000	—	31 Dec 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.26%	269,359	$4,372,000	—	31 Dec 2019	13F
Point72 Asset Management, L.P.	13F	Company	0.25%	265,199	$4,304,000	—	31 Dec 2019	13F
Rhenman & Partners Asset Management AB	13F	Company	0.24%	250,000	$4,058,000	—	31 Dec 2019	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.24%	248,045	$4,026,000	—	31 Dec 2019	13F
Pinz Capital Management, LP	13F	Company	0.21%	224,000	$3,636,000	—	31 Dec 2019	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.21%	217,372	$3,551,000	—	31 Dec 2019	13F
S.c.a. Candriam	13F	Individual	0.21%	215,000	$3,489,000	—	31 Dec 2019	13F
OSTERWEIS CAPITAL MANAGEMENT INC	13F	Company	0.2%	209,780	$3,405,000	—	31 Dec 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.15%	155,712	$2,526,000	—	31 Dec 2019	13F
Maven Securities LTD	13F	Company	0.14%	146,498	$2,362,000	—	31 Dec 2019	13F
Global IMC LLC	13F	Company	0.13%	136,443	$2,214,000	—	31 Dec 2019	13F
SEI INVESTMENTS CO	13F	Company	0.11%	111,451	$1,806,000	—	31 Dec 2019	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.1%	109,199	$1,772,000	—	31 Dec 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.1%	107,908	$1,751,000	—	31 Dec 2019	13F
Knights of Columbus Asset Advisors LLC	13F	Company	0.1%	106,963	$1,736,000	—	31 Dec 2019	13F
Informed Momentum Co LLC	13F	Company	0.1%	105,429	$1,711,000	—	31 Dec 2019	13F
MORGAN STANLEY	13F	Company	0.09%	89,888	$1,459,000	—	31 Dec 2019	13F
Swiss National Bank	13F	Company	0.08%	88,950	$1,444,000	—	31 Dec 2019	13F
Palo Alto Investors LP	13F	Company	0.08%	88,590	$1,438,000	—	31 Dec 2019	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.08%	88,100	$1,430,000	—	31 Dec 2019	13F
Sio Capital Management, LLC	13F	Company	0.08%	87,700	$1,423,000	—	31 Dec 2019	13F

Institutional Holders of Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) as of Q1 2020

As of 31 Mar 2020, Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) was held by 126 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 49,442,358 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., JPMORGAN CHASE & CO, ArrowMark Colorado Holdings LLC, FRANKLIN RESOURCES INC, Essex Woodlands Management, Inc., VANGUARD GROUP INC, ALLIANCEBERNSTEIN L.P., Capital World Investors, and JENNISON ASSOCIATES LLC. This page lists 126 institutional shareholders reporting positions in this security for the Q1 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders

130

Q1 2020 holders

126

Holder diff

-4

Investor	Q4 2019 Shares	Q1 2020 Shares	Share Diff	Share Chg %	Q4 2019 Value $	Q1 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.